Joyner, who heads CVS’s pharmacy-benefit business Caremark, will succeed Karen Lynch.

The website you are visiting is protected and accelerated by Incapsula. Your computer may have been infected by malware and ...

Cigna surpassed Wall Street estimates for third-quarter profit on Thursday, driven by high demand for biosimilars of a ...

Good morning, and TGIF. With the 118th Congress winding down, what issues do you hope lawmakers will tackle next session?

Cigna’s quarterly earnings beat Wall Street expectations, providing relief to investors who had soured on the struggles of health insurers’ Medicare and Medicaid businesses. The company, parent of a ...

Cold water has been tossed on the idea that CVS Health would break up the company and sell off health or pharmacy benefits from assets that provide ... story a few weeks ago in the Wall Street Journal ...

Therefore, entities like insurance companies and TPAs often outsource the management of pharmacy benefits to one of the major PBMs. [27] TPAs are independent benefit contractors that work with ...

CVS Health's David Joyner is expected to address how he will better manage rising patient costs in the Medicare business than ...

Abelson and Robbins found numerous instances where pharmacy benefit managers created a business environment inhospitable to many local independently-owned pharmacies. The reporters discovered ...

Pharmacy Benefit Services sales increased 50% to ... The adjusted EPS of $7.51, increased from $6.77 a year ago, beat the Wall Street estimate of $7.20. Guidance: Cigna reaffirms 2024 adjusted ...

That provides an explanation for Lynch's departure, and for investors previously calling for the company to break up, an outcome Joyner ruled out in an interview with the Wall Street Journal.